Impact Factor: 1.4

Artículos originales \ Editorial

The challenging pathway to TAVI: in memory of Alain Cribier

Eulogio García,a, Leire Unzué,b and Rodrigo Teijeirob

aServicio de Cardiología Intervencionista, Hospital Gregorio Marañón, Hospital Clínico San Carlos, Hospital Montepríncipe y Hospital Moncloa, Madrid, Spain

bServicio de Cardiología Intervencionista, Hospital Montepríncipe y Hospital Moncloa, Madrid, Spain

DOI: https://doi.org/10.24875/RECICE.M24000457

Disponible online: 13/06/2024

Clinical evaluation requirements under the new European Union medical device regulation

Gloria Hernández Hernández

Centro Nacional de Certificación de Productos Sanitarios, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, Spain

DOI: https://doi.org/10.24875/RECICE.M24000449

Disponible online: 20/05/2024

Misconceptions and misunderstandings hampering medical research and progress

Carmen Carazo-Díaz,a,b Luis Prieto Valiente,a,b and Manuel Martínez-Sellésc,d,e,f,

aCátedra Internacional de Análisis Estadístico y Big Data, Facultad de Medicina, UCAM Universidad Católica de Murcia, Guadalupe de Maciascoque, Murcia, Spain

bADA.RT Advanced Data Analysis Research and Teaching, Madrid, Spain

cServicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain

dCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

eFacultad de Ciencias Biomédicas y de la Salud, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain

fFacultad de Medicina, Universidad Complutense, Madrid, Spain

DOI: https://doi.org/10.24875/RECICE.M23000434

Disponible online: 27/02/2024

Ventricular pressure-volume loop and other heart function metrics can elucidate etiology of failure of TAVI and interventions

Zahra Keshavarz-Motameda,b,

aDepartment of Mechanical Engineering, McMaster University, Hamilton, Ontario, Canada

bSchool of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada

DOI: https://doi.org/10.24875/RECICE.M23000438

Disponible online: 05/02/2024

Drug-coated balloons on the “big stage”: is this technology ready for an all-comer population with de novo lesions?

Wojciech Wańha,a,b Sylwia Iwańczyk,b,c and Bernardo Corteseb,d,

aDepartment of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland

bDCB Academy, Milano, Italy

c1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland

dCardiovascular Research Center, Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy

DOI: https://doi.org/10.24875/RECICE.M23000437

Disponible online: 05/02/2024

Implementing an ANOCA clinic

Thabo Mahendiran,a,b and Bernard De Bruynea,b,

aCardiovascular Center Aalst, OLV Clinic, Aalst, Belgium

bDepartment of Cardiology, Lausanne University Hospital, Lausanne, Switzerland

REC Interv Cardiol. 2024;6:61-62

Percutaneous pulmonary valve implantation in native outflow tracts: has the time come?

Pablo Merás Colunga, and Santiago Jiménez Valero

Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain

REC Interv Cardiol. 2024;6:63-66

Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now?

Ignacio J. Amat-Santos,a,b, and Juan Pablo Sánchez-Lunaa

aServicio de Cardiología, Hospital Clínico Universitario, Valladolid, Spain

bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

REC Interv Cardiol. 2024;6:3-6

Vascular closure devices: the jury is still out

Juan M. Ruiz-Nodar,a,b, and Javier Pineda Rocamoraa

aUnidad de Hemodinámica, Servicio de Cardiología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain

bDepartamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain

REC Interv Cardiol. 2024;6:1-2